Skip Navigation



BJA Advance Access published online on May 2, 2009

British Journal of Anaesthesia, doi:10.1093/bja/aep091
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
102/6/779    most recent
aep091v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ng, K. F. J.
Right arrow Articles by Chiu, K. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ng, K. F. J.
Right arrow Articles by Chiu, K. Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2009]. Published by Oxford University Press on behalf of The Board of Directors of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournal.org

Value of a single preoperative PFA-100® measurement in assessing the risk of bleeding in patients taking cyclooxygenase inhibitors and undergoing total knee replacement{dagger}

K. F. J. Ng1,2,*, J.-C. Lawmin3, S. F. Tsang1, W. M. Tang4 and K. Y. Chiu5

1 Department of Anaesthesiology
2 Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hongkong, Room 424, Block K, Queen Mary Hospital Hongkong, Hongkong SAR, China
3 Department of Anaesthesia, Duchess of Kent Children's Hospital, Hong Kong, China
4 Department of Orthopaedics, Hongkong Sanatorium and Hospital, Hong Kong, China
5 Department of Orthopaedics and Traumatology, LKS Faculty of Medicine, The University of Hongkong, Hong Kong, China

* Corresponding author. E-mail: jkfng{at}hku.hk

Background: The usefulness of the PFA-100® in assessing the risk of bleeding in non-cardiac surgery is not clear. This study aims to examine this by correlating preoperative PFA-100® measurement with perioperative bleeding in patients receiving cyclooxygenase (COX) inhibitors.

Methods: PFA-100® with adenosine-5'-diphosphate (ADPCT) and epinephrine (EPICT) cartridges were measured before operation in consecutive patients undergoing elective total knee replacement and taking different COX inhibitors. Surgery and anaesthesia were performed by the same team using standardized techniques. Intraoperative blood loss and postoperative drain output were recorded by anaesthetists and nurses blinded to the PFA-100® measurements. Surgeons, similarly blinded, were asked to rate the quality of haemostasis. Correlation was sought between these data and PFA-100® measurements.

Results: Thirty patients were studied, involving 51 knees. Preoperative PFA-100® EPICT was correlated with drain output (r=0.30, P=0.03). The correlation becomes stronger when a 20% in vitro haemodiluted sample was used for measurement (r=0.42, P=0.01). Receiver-operating characteristic curve analysis using the diluted measurements [area under curve (AUC) 0.74 (95% CI 0.54–0.94)] suggested using a cut-off value of 188 s for EPICT, which will predict excessive drain output with 89% sensitivity, 54% specificity, and a likelihood ratio of 1.93. Diluted EPICT was also correlated with surgeon rating of haemostasis (r=0.36, P=0.04) although none of the measurements correlated with intraoperative blood loss.

Conclusions: Preoperative PFA-100® prolongation is correlated with increased postoperative drain output. It can be a potentially useful preoperative measurement in patients taking COX inhibitors.

Keywords: blood, platelets; blood, anticoagulants; complications, haemorrhage; non-steroidal anti-inflammatory drugs; surgery, postoperative period


{dagger} Preliminary results of this study have been presented at (i) HAA 2007, Combined Annual Scientific Meeting of the Haematology Society of Australia and New Zealand, the Australian and New Zealand Society of Blood Transfusion, and the Australasian Society of Thrombosis and Haemostasis and (ii) ISLH 2008 XXIst International Symposium on Technological Innovations in Laboratory Hematology [Int J Lab Hematol 2008; 30 (Suppl. 1): 103 A419].


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.